
Clinical trials constitute the single most expensive component of the entire drug development process. In particular, clinical trial operations represent one of the most resource-intensive areas within a biopharmaceutical company and often involve tedious, manual processes for collecting, aggregating and rationalizing information from a wide variety of data sources.
A CTMS (Clinical Trials Management System) yields immediate efficiencies and cost savings for clinical operations. By providing a single, centralized system to orchestrate operational and administrative activities, a CTMS allows biopharmaceutical companies and CROs to intelligently manage the complexities of clinical trials. Instead of relying on disparate “islands” of information, often in direct conflict with each other, CTMS users benefit from sharing consistent trial data across the entire enterprise. This allows the sponsor organization to streamline processes, appropriately respond to current statuses and proactively manage their trials.
IMPACT CTMS is a leading solution for pharmaceutical and biotechnology companies of all sizes. With IMPACT CTMS, you will benefit from its global capabilities, adaptive framework and exceptional breadth of functionality. IMPACT CTMS is available as a SaaS solution enabling rapid and flexible deployment. Customers can also choose to implement IMPACT CTMS as an on-premise solution and install within their operating environment. Product modules cover the management of trial progress, planning, monitoring activities, supplies and finance.
Phase I Solution
Initiator is a leading Phase I solution, specifically designed to meet the unique needs of the early phase trials. It is a complete Phase I solution that facilitates effective planning, management and tracking all within a single central application by supporting the entire study lifecycle all the way from recruitment to preparation of reports.